Miyauchi Yuu
(宮内 優)
Modified on: 02/01
Profile Information
- Affiliation
- 講師, 衛生化学研究室, 崇城大学薬学部
- Degree
-
修士(創薬科学)(九州大学大学院薬学府)博士(創薬科学)(九州大学大学院薬学府)
- Researcher number
- 50799947
- J-GLOBAL ID
- 201801000240951876
- researchmap Member ID
- B000346477
Research Interests
5Research Areas
2Research History
4-
Nov, 2016 - Mar, 2020
-
Apr, 2015 - Apr, 2015
Education
3-
Apr, 2012 - Mar, 2015
-
Apr, 2010 - Mar, 2012
-
Apr, 2006 - Mar, 2010
Committee Memberships
1-
Apr, 2021 - Mar, 2023
Major Awards
9-
Nov, 2021
-
Sep, 2021
Major Papers
21-
The Journal of toxicological sciences, 48(5) 263-272, May, 2023 Peer-reviewedLead authorCorresponding author
-
Drug metabolism and pharmacokinetics, 35(5) 466-474, Oct, 2020 Peer-reviewedLead authorCorresponding author
-
British journal of pharmacology, 177(5) 1077-1089, Mar, 2020 Peer-reviewedLead author
-
Molecular pharmacology, 88(4) 800-12, Oct, 2015 Peer-reviewedLead author
Misc.
11-
日本薬物動態学会ニュースレター, 37(6), Dec, 2022
-
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 142(11) 1169-1175, Nov, 2022 Peer-reviewedInvitedCorresponding author
-
環境・衛生薬学トピックス, Jun 1, 2022
-
日本薬学会九州支部大会講演要旨集, 38th (CD-ROM), 2021
-
Biological & pharmaceutical bulletin, 44(11) 1635-1644, 2021 Peer-reviewedInvitedLead authorCorresponding author
-
ファルマシア, 56(10), 2020
-
日本薬物動態学会ニュースレター, 34(5), 2019
-
日本薬物動態学会ニュースレター, 33(4), 2018
-
日本薬物動態学会ニュースレター, 30(1), 2015
-
Fifty Years of Cytochrome P450 Research, 307-326, Jan 1, 2014
-
臨床薬理の進歩, 9-16, 2013
Presentations
4-
PRIS 2023 in 2023 ICCP450/JSSX International Joint Meeting (Educational Lecture), Sep 27, 2023 Invited
-
第38回日本薬学会九州支部大会(受賞講演), Nov, 2021
-
フォーラム2021衛生薬学・環境トキシコロジー(受賞講演), Sep, 2021
Teaching Experience
4-
Apr, 2020 - Present
-
Apr, 2020 - Present
-
Apr, 2020 - Present
-
Apr, 2020 - Mar, 2022
Professional Memberships
5-
Apr, 2021 - Present
-
Mar, 2019 - Present
-
Feb, 2019 - Present
-
May, 2010 - Present
-
Oct, 2009 - Present
Major Research Projects
13-
第43回 研究助成金, 薬学研究奨励財団, Apr, 2023 - Mar, 2025
-
科学研究費助成事業 若手研究, 若手研究, 日本学術振興会, Apr, 2022 - Mar, 2024